Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milrinone vs Levosimendan in Neonates Undergoing Cardiovascular Surgery
NCT01576094Phase 2Completed
- Sponsor
- Hospital La Paz Institute for Health Research
- Start
- Nov 2009
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of levosimendan in low cardiac output syndrome (LCOS) (2 arms), sponsored by Hospital La Paz Institute for Health Research. Primary endpoint: Perfusion-oxygenation assessed by Near-Infrared Spectroscopy (NIRS) at 96 hours. Started Nov 2009; status: completed.
02
Drugs
levosimendan
03
Conditions
low cardiac output syndrome (LCOS)
Beyond the preview
Go deeper on NCT01576094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01576094.